Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lynn Kirkpatrick currently holds 381,851 shares of Ensysce Biosciences, Inc. (ENSC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lynn Kirkpatrick has been a net buyer of ENSC stock. They have purchased $48.6K and sold $0 worth of shares.
Lynn Kirkpatrick's most recent insider trade was on May 26, 2022, when they purchased 27,000 shares at $0.53 per share.
Lynn Kirkpatrick serves as Executive at Ensysce Biosciences, Inc. (ENSC). They have executed 5 insider transactions totaling $48.6K over their tenure at the company.
Lynn Kirkpatrick holds the position of Executive at Ensysce Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Lynn Kirkpatrick has shown a buying trading pattern, with $48.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Lynn Kirkpatrick was on May 25, 2022, when they purchased $34.3K worth of ENSC shares. This transaction involved 70,000 shares at $0.49 per share.
Lynn Kirkpatrick currently owns 381,851 shares of Ensysce Biosciences, Inc. (ENSC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lynn Kirkpatrick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lynn Kirkpatrick has 5 Form 4 filings on record as an insider at Ensysce Biosciences, Inc..
Set alerts for Lynn Kirkpatrick and 40,000+ other insiders.